Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc

Authors

Akira Kurosaki (ORCID: https://orcid.org/0000-0002-2562-3840)
Shinichiro Minobe (ORCID: https://orcid.org/0000-0002-9493-1935)
Guillermo Villacampa (ORCID: https://orcid.org/0000-0003-4868-6585)
Shin Nishio (ORCID: https://orcid.org/0000-0003-2526-630X)
Hiroshi Nishio (ORCID: https://orcid.org/0000-0002-4938-416X)
Aikou Okamoto (ORCID: https://orcid.org/0000-0002-5079-0464)
Munetaka Takekuma (ORCID: https://orcid.org/0000-0002-0807-1845)
Ana Oaknin (ORCID: https://orcid.org/0000-0002-3592-7194)
Mayu Yunokawa (ORCID: https://orcid.org/0000-0001-7354-6977)
Koji Nishino (ORCID: https://orcid.org/0000-0001-6218-8641)
Satoshi Yamaguchi (ORCID: https://orcid.org/0000-0002-8260-6174)

Institutions

Jikei University School of Medicine (JP)
Breast Cancer Research Foundation (US)
Shizuoka Cancer Center (JP)
Kurume University Hospital (JP)
Keio University Hospital (JP)
Niigata University Medical and Dental Hospital (JP)
Vall d'Hebron Hospital Universitari (ES)
Saitama International Medical Center (JP)
The Cancer Institute Hospital (JP)
Hyogo Prefectural Cancer Center (JP)
Vall d'Hebron Institute of Oncology (ES)
Saitama Medical University (JP)

Publication Details

Journal: Journal of Gynecologic Oncology
Published: 2025-01-01
DOI: https://doi.org/10.3802/jgo.2025.36.e116
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc

Akira Kurosaki, Shinichiro Minobe, Guillermo Villacampa, Shin Nishio et al.

Jan 1, 2025

Journal of Gynecologic Oncology

Cancer Immunotherapy and Biomarkers

article

Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc

Akira Kurosaki, Shinichiro Minobe, Guillermo Villacampa, Shin Nishio, Hiroshi Nishio, Aikou Okamoto, Munetaka Takekuma, Ana Oaknin, Mayu Yunokawa, Koji Nishino, Satoshi Yamaguchi

January 1, 2025article en

Abstract

No abstract available for this paper.

Journal of Gynecologic OncologyVol. 36(6)

Jikei University School of Medicine (JP), Breast Cancer Research Foundation (US), Shizuoka Cancer Center (JP), Kurume University Hospital (JP), Keio University Hospital (JP), Niigata University Medical and Dental Hospital (JP), Vall d'Hebron Hospital Universitari (ES), Saitama International Medical Center (JP), The Cancer Institute Hospital (JP), Hyogo Prefectural Cancer Center (JP), Vall d'Hebron Institute of Oncology (ES), Saitama Medical University (JP)

Openalex Percentile: Top 65%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc — Akira Kurosaki, Shinichiro Minobe, et al. · Journal of Gynecologic Oncology (2025) | TGRS Research Map | TGRS